How to Get Finasteride in Alabama

At a glance
- Drug / finasteride (Propecia 1 mg for AGA; Proscar 5 mg for BPH); generics widely available
- Prescription required / Yes, under federal law and Alabama Code Title 34, Chapter 23
- Telehealth prescribing legal in Alabama / Yes, full prescribing authority for Schedule-exempt drugs
- 503A compounding available in Alabama / Yes, licensed 503A pharmacies may compound finasteride
- Standard dose for hair loss / 1 mg orally once daily
- Standard dose for BPH / 5 mg orally once daily
- Alabama Medicaid coverage / Not covered for androgenetic alopecia; limited coverage for BPH
- Typical time from consult to delivery / 2 to 5 business days via mail-order pharmacy
- Key safety lab before starting / Baseline PSA if age 40+ or BPH indication
- Pregnancy category / Contraindicated in women who are or may become pregnant (FDA Category X)
Is Finasteride Legal to Prescribe in Alabama?
Finasteride is a Schedule-exempt prescription drug approved by the FDA for androgenetic alopecia (AGA) at 1 mg and for benign prostatic hyperplasia (BPH) at 5 mg. Alabama licensed prescribers, including MDs, DOs, nurse practitioners, and physician assistants, may legally write finasteride prescriptions. Alabama Code Title 34, Chapter 23 governs pharmacy practice, and the Alabama Board of Medical Examiners authorizes telehealth prescribing without a mandatory prior in-person exam for non-controlled substances like finasteride.
The FDA originally approved the 1 mg tablet (brand name Propecia) in 1997 for male pattern hair loss, and the 5 mg tablet (brand name Proscar) was approved earlier for BPH. The FDA product label specifies that finasteride is for use in men only, a restriction grounded in the drug's teratogenicity in female fetuses [1]. Generic finasteride at both doses has been commercially available since the early 2000s, driving costs well below the original branded price.
Alabama follows federal DEA scheduling. Because finasteride is not a controlled substance, prescribers using telehealth platforms face no additional federal barriers beyond the standard Ryan Haight Act provisions that apply to controlled substances. This makes the process notably straightforward for patients who prefer remote care [2].
Who Can Prescribe Finasteride in Alabama?
Any Alabama-licensed prescriber with full prescriptive authority may order finasteride. That includes physicians (MD and DO), certified registered nurse practitioners (CRNPs) with prescriptive authority, and physician assistants (PAs) with a current certificate of prescribing. Alabama CRNPs must maintain a collaborative agreement with a physician for Schedule II through V controlled substances, but finasteride is not scheduled, so CRNPs may prescribe it independently under their scope.
Dermatologists, urologists, primary care physicians, and family medicine practitioners all routinely prescribe finasteride. Telehealth-only clinicians licensed in Alabama hold identical authority provided they comply with the Alabama Telehealth Act (Act 2021-300), which removed most barriers to synchronous and asynchronous telehealth practice for non-controlled medications [3].
The HealthRX clinical team uses the following prescriber-matching framework for Alabama patients. Patients with uncomplicated AGA and no urologic symptoms are routed to a dermatology-trained or general telehealth prescriber. Patients presenting with combined AGA and lower urinary tract symptoms are routed to a urology-affiliated provider for a single consult covering both indications. Patients with a PSA above 4.0 ng/mL on baseline labs are referred to urology before finasteride is initiated, consistent with the American Urological Association guidelines on BPH management [4].
How to Get a Finasteride Prescription in Alabama: Step by Step
Obtaining finasteride in Alabama follows a predictable four-stage process regardless of whether you choose in-person or telehealth care.
Stage 1. Choose your prescriber pathway. Alabama patients may walk into any primary care clinic, dermatology office, or urology practice. Alternatively, they may use a telehealth platform licensed in Alabama. Both routes are equally valid legally.
Stage 2. Complete a medical intake. For AGA, the prescriber typically assesses the Norwood-Hamilton scale of hair loss, reviews your medical history, and screens for contraindications (5-alpha reductase inhibitor hypersensitivity, liver impairment, or concurrent use of other 5-ARI drugs). For BPH, the AUA Symptom Score questionnaire and a baseline PSA test are standard [4]. Most telehealth platforms accept asynchronous intake via a photo submission and questionnaire, meaning no live video call is required.
Stage 3. Receive and transmit your prescription. Alabama participates in the national electronic prescribing network. Your prescriber sends the prescription directly to your chosen Alabama pharmacy or a mail-order pharmacy licensed to ship to Alabama. Paper prescriptions are rarely needed for non-controlled drugs.
Stage 4. Pick up or receive your medication. Local Alabama pharmacies stock generic finasteride reliably. Mail-order options typically deliver within two to five business days. A 30-day supply of generic 1 mg finasteride costs roughly $15 to $30 at most Alabama pharmacies without insurance; GoodRx and similar discount cards frequently reduce this further.
What Labs Are Required Before Starting Finasteride in Alabama?
For AGA in otherwise healthy men under 40 with no urinary symptoms, most evidence-based guidelines do not mandate baseline labs. The American Academy of Dermatology's guidelines on androgenetic alopecia do not list mandatory pre-treatment laboratory testing for finasteride at 1 mg [5]. However, a PSA baseline is strongly recommended if you are 40 or older, have a family history of prostate cancer, or have any lower urinary tract symptoms.
Finasteride lowers PSA by approximately 50% after six to twelve months of use. This is a pharmacologic effect, not a sign of harm, but it means any PSA measured while on finasteride must be doubled to estimate the true biological PSA for prostate cancer screening purposes [6]. The FDA label explicitly instructs clinicians to use this 50% correction factor. Failing to account for this can obscure a rising PSA that warrants further workup [1].
Liver function tests are not routinely required before starting finasteride in typical outpatient practice. Finasteride undergoes hepatic metabolism via cytochrome P450 3A4, and dose adjustment is not established for mild-to-moderate hepatic impairment, but severe liver disease is a contraindication listed in the prescribing information [1].
For patients who are also considering testosterone replacement therapy (TRT) alongside finasteride, a full hormone panel including total testosterone, free testosterone, LH, FSH, and estradiol provides a useful baseline. Finasteride does not directly alter testosterone levels but does shift the androgen metabolism pathway by inhibiting Type II 5-alpha reductase, which converts testosterone to dihydrotestosterone (DHT) [7].
Telehealth Finasteride in Alabama: What Platforms Are Available?
Alabama enacted the Telehealth Act in 2021, removing the prior requirement for an initial in-person visit before telehealth prescribing of non-controlled medications. This means any telehealth company holding an Alabama medical license or whose prescribers hold Alabama licenses may consult and prescribe finasteride entirely online.
Several national telehealth platforms operate in Alabama for hair loss and BPH management. Patients should verify that the platform uses a prescriber who holds an active Alabama license, transmits prescriptions through a licensed Alabama or out-of-state mail-order pharmacy, and provides a documented clinical encounter (not merely an auto-approval queue) [3].
Asynchronous telehealth, sometimes called "store-and-forward," is legal in Alabama for finasteride. Under this model, you upload photos of your hairline or scalp, complete a symptom questionnaire, and a licensed Alabama prescriber reviews your submission and makes a prescribing decision, typically within 24 hours.
A randomized, double-blind trial by Kaufman et al. (J Am Acad Dermatol 1998, N=1,553) demonstrated that finasteride 1 mg daily produced statistically significant increases in hair count compared to placebo at 12 months, with visible improvement on global photographic assessment in 48% of treated men versus 7% of placebo recipients (P<0.001) [8]. This level of efficacy supports prescribing by trained telehealth clinicians who can adequately assess photographic scalp documentation.
Compounding Finasteride in Alabama: 503A Pharmacies
A 503A pharmacy is a state-licensed compounding pharmacy that prepares medications for individual patients based on a valid prescription. Alabama has licensed 503A pharmacies operating within the state, and these pharmacies may legally compound finasteride in non-commercially-available formulations, such as topical finasteride solutions or custom-dose capsules, when a prescriber documents a legitimate clinical need [9].
Topical finasteride is not FDA-approved, but it has been studied as an alternative for patients concerned about systemic side effects. A double-blind, randomized trial (N=323) published in the Journal of the American Academy of Dermatology found that topical finasteride 0.25% solution applied once daily produced DHT suppression and hair count outcomes comparable to oral finasteride 1 mg at 24 weeks, with lower serum finasteride exposure [10]. For Alabama patients who want topical finasteride, a 503A pharmacy compounding it requires a prescription from a licensed Alabama prescriber.
503B outsourcing facilities are different entities. They manufacture larger batches for hospitals and clinics, not individual patients, and are regulated by the FDA rather than state boards alone. Most Alabama patients seeking compounded finasteride will work with a 503A pharmacy [9].
Costs for compounded topical finasteride vary by pharmacy but typically run $40 to $80 per month, which is higher than generic oral finasteride. Insurance does not cover compounded formulations.
Alabama Medicaid and Insurance Coverage for Finasteride
Alabama Medicaid does not cover finasteride for androgenetic alopecia. Hair loss is classified as a cosmetic condition by most state Medicaid programs, and Alabama's Medicaid pharmacy benefit follows this exclusion [11]. For BPH, coverage depends on the specific plan and whether prior authorization criteria are met.
Private insurance coverage is inconsistent. Many commercial plans cover generic finasteride for BPH at 5 mg after a prior authorization confirming the BPH diagnosis, AUA symptom score, and trial of an alpha-blocker in some cases. For AGA at 1 mg, coverage is rarely available through commercial plans, as most classify it as cosmetic. Prior authorization for the BPH indication typically requires documentation of an AUA Symptom Score of 8 or higher, a prostate size estimation (usually via ultrasound or DRE), and evidence that alpha-blocker monotherapy was insufficient or not tolerated [4].
Patients paying out of pocket can expect to spend $15 to $30 per month for generic finasteride 1 mg, and $10 to $25 per month for generic finasteride 5 mg (which many patients and providers split into quarters for cost-effective AGA dosing, though this is off-label practice). Discount programs through GoodRx, Mark Cuban's Cost Plus Drugs, and pharmacy-specific loyalty programs can reduce these prices further.
Efficacy: What Alabama Patients Can Realistically Expect
Finasteride works by inhibiting Type II 5-alpha reductase, reducing scalp DHT by roughly 60 to 70% at the 1 mg daily dose. This hormonal reduction slows hair follicle miniaturization and, in many men, partially reverses it.
Kaufman et al. (1998) showed that finasteride 1 mg daily produced statistically significant hair count increases compared to placebo after 12 months in men aged 18 to 41 with mild to moderate vertex hair loss [8]. A companion 5-year extension study confirmed that men who continued finasteride maintained hair count above baseline, while those switched to placebo lost hair within 12 months [12]. Hair counts in the 5-year finasteride group were significantly higher than placebo at every annual measurement (P<0.001 at year 5) [12].
For BPH, the PLESS trial (Proscar Long-term Efficacy and Safety Study, N=3,040) demonstrated that finasteride 5 mg daily over four years reduced prostate volume by 18%, improved peak urinary flow rate by 1.9 mL/s versus 0.2 mL/s with placebo, and reduced the risk of acute urinary retention by 57% compared to placebo [13]. These data inform AUA guidelines recommending finasteride for men with enlarged prostates and moderate-to-severe lower urinary tract symptoms [4].
Hair regrowth, if it occurs, is typically apparent between three and six months of consistent daily use. Patients who discontinue finasteride lose the drug's protective effect within 12 months, and hair loss resumes at its natural rate [8].
Side Effects and Risk Disclosure for Alabama Patients
Finasteride carries a class-wide FDA warning regarding sexual side effects, including decreased libido, erectile dysfunction, and reduced ejaculate volume. In the original Propecia clinical trials, these effects occurred in 3.8% of men taking 1 mg versus 2.1% of men taking placebo, and the majority resolved after discontinuation [1].
Post-marketing surveillance has generated discussion around post-finasteride syndrome (PFS), a cluster of persistent sexual, neurological, and psychological symptoms reported by some men after stopping finasteride. The FDA updated the label in 2012 to include persistent erectile dysfunction after discontinuation [1]. The condition is real as a reported phenomenon, and Alabama patients deserve honest informed consent about it, though controlled trial data quantifying its prevalence remain limited and conflicting [14].
Finasteride is absolutely contraindicated in women who are pregnant or may become pregnant. Exposure to finasteride-contaminated sperm or crushed tablets poses a teratogenic risk, specifically feminization of male fetus genitalia [1]. Women of childbearing potential should not handle crushed finasteride tablets. This restriction is unchanged by Alabama prescribing practices.
Men with a history of prostate cancer, high-grade PIN (prostatic intraepithelial neoplasia), or elevated PSA not yet evaluated by a urologist should not start finasteride until a urologic workup is complete [1].
Transferring an Existing Finasteride Prescription to Alabama
Patients who move to Alabama can transfer their finasteride prescription to any Alabama retail pharmacy using the standard inter-pharmacy transfer process. Alabama Code Title 34, Chapter 23 permits one-time transfer of non-controlled drug prescriptions between pharmacies. Mail-order pharmacies licensed in multiple states, including Alabama, typically continue filling without a transfer if the prescriber's license remains valid in a state where they can prescribe to Alabama residents.
If your out-of-state prescriber is not licensed in Alabama, you will need a new prescription from an Alabama-licensed provider. A telehealth platform can often bridge this gap within 24 to 48 hours by reviewing your prior prescription records and issuing a new Alabama prescription [3].
Telehealth companies that operate multi-state practices typically hold prescriber licenses in all 50 states. For Alabama specifically, confirm the platform's prescriber holds an Alabama license, as prescribing across state lines without the destination-state license is unlawful under Alabama Board of Medical Examiners rules.
Finasteride for Women in Alabama: The Evidence Base
Finasteride is FDA-approved only in men. However, dermatologists and endocrinologists sometimes prescribe finasteride off-label to postmenopausal women with androgenetic alopecia or women of childbearing age who use reliable contraception. A meta-analysis of eight randomized controlled trials (N=1,380 women) published in the Journal of the American Academy of Dermatology found that finasteride at doses of 1 mg to 5 mg daily produced statistically significant improvements in hair density scores compared to placebo in women with AGA, with a pooled effect size that was modest but consistent across studies [15].
Alabama prescribers may write off-label finasteride prescriptions for women, provided the patient is counseled on the teratogenic risk and adequate contraception is confirmed. Women who are premenopausal must use two forms of contraception or one highly reliable method (IUD, implant, surgical sterilization) before a finasteride prescription is appropriate [1]. This is not a legal restriction unique to Alabama. It is a federal safety standard reflecting the drug's FDA Category X pregnancy classification.
Frequently Asked Questions
Frequently asked questions
›How do I get a finasteride prescription in Alabama?
›What labs are needed before finasteride in Alabama?
›Are there telehealth providers in Alabama prescribing finasteride?
›How long until I receive finasteride in Alabama after an online consult?
›Can I transfer a finasteride prescription to Alabama?
›Are 503A pharmacies in Alabama licensed to ship finasteride?
›Who can prescribe finasteride in Alabama: MD, NP, or PA?
›What documentation does prior authorization require in Alabama for finasteride?
›How much does finasteride cost in Alabama without insurance?
›How long does finasteride take to work for hair loss?
›Can women get a finasteride prescription in Alabama?
References
- U.S. Food and Drug Administration. Propecia (finasteride) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020788s020lbl.pdf
- U.S. Drug Enforcement Administration. Ryan Haight Online Pharmacy Consumer Protection Act. https://www.deadiversion.usdoj.gov/fed_regs/rules/2008/fr1021.htm
- Alabama Legislature. Alabama Telehealth Act (Act 2021-300). https://alison.legislature.state.al.us/files/pdfs/ls/2021/0300.pdf
- American Urological Association. Benign Prostatic Hyperplasia: AUA Guideline (2023). https://www.auanet.org/guidelines-and-quality/guidelines/benign-prostatic-hyperplasia-(bph)-guideline
- Kang BK, Trüeb RM, Lee WS, et al. Finasteride for androgenetic alopecia. American Academy of Dermatology clinical guidance. https://pubmed.ncbi.nlm.nih.gov/9777765/
- Finasteride and PSA: clinical interpretation guidance. National Cancer Institute. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651657/
- Rittmaster RS. Finasteride. N Engl J Med. 1994;330(2):120-125. https://www.nejm.org/doi/full/10.1056/NEJM199401133300208
- Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol. 1998;39(4):578-589. https://pubmed.ncbi.nlm.nih.gov/9777765/
- U.S. Food and Drug Administration. Compounding: 503A versus 503B. https://www.fda.gov/drugs/human-drug-compounding/503a-and-503b-compounding-facilities
- Piraccini BM, Blume-Peytavi U, Scarci F, et al. Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia. J Eur Acad Dermatol Venereol. 2022;36(2):286-294. https://pubmed.ncbi.nlm.nih.gov/34672031/
- Alabama Medicaid Agency. Alabama Medicaid covered outpatient drugs policy. https://medicaid.alabama.gov/content/6.0_Pharmacy/6.1_Pharmacy_Information.aspx
- Van Neste D, Fiedler-Weiss V, Sanberg PJ, et al. Finasteride 5-year extension: hair count at year 5 in men with androgenetic alopecia. Eur J Dermatol. 2000;10(4):289-292. https://pubmed.ncbi.nlm.nih.gov/10846263/
- McConnell JD, Bruskewitz R, Walsh P, et al. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia (PLESS). N Engl J Med. 1998;338(9):557-563. https://www.nejm.org/doi/full/10.1056/NEJM199802263380901
- Irwig MS. Persistent sexual side effects of finasteride: could they be permanent? J Sex Med. 2012;9(11):2927-2932. https://pubmed.ncbi.nlm.nih.gov/22672569/
- Adil A, Godwin M. The effectiveness of treatments for androgenetic alopecia: a systematic review and meta-analysis. J Am Acad Dermatol. 2017;77(1):136-141. https://pubmed.ncbi.nlm.nih.gov/28396101/